Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linrong Pang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Nephrology|April 18, 2025
Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1/Snail pathwayXiaohong Ma, Binghe Guan, Linrong Pang
Drug and Chemical Toxicology|December 29, 2024
Ginsenoside Rk1 exerts protective effects of LPS-induced podocyte apoptosis and inflammation by inactivating JAK2/STAT3 and NF-κB pathwaysXiaohong Ma, Linrong Pang, Feizhuang Shi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 13, 2025
Retraction Note: Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1Jinger Lu, Linrong Pang, Bo Zhang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 12, 2021
Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1Jinger Lu, Linrong Pang, Bo Zhang, et al.
Oncology Research and Treatment|September 26, 2015
Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell CarcinomaJia Huang, Wenhao Hu, Linrong Pang, et al.
Medicine|January 12, 2024
Whether specific genetic feature predicted immunotherapy efficacy: A case reportJun Chen, Linrong Pang, Lianxiang He, et al.
British Journal of Cancer|January 13, 2026
ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184Ze Rong, Jing Xing, Liangpei Wu, et al.
Oncotargets and Therapy|August 11, 2021
Acquired <i>ALK</i> Resistance Mutations Identified from Liquid Biopsy in an <i>ALK</i>-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case ReportBin Yao, Xue Han, Linrong Pang, et al.
Oncology Letters|January 19, 2018
Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2Linrong Pang, Jinger Lu, Jia Huang, et al.
Frontiers in Medicine|August 28, 2020
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the LiteratureHui Li, Xin Zhou, Ding Zhang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Nephrology|April 18, 2025
Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1/Snail pathwayXiaohong Ma, Binghe Guan, Linrong Pang
Drug and Chemical Toxicology|December 29, 2024
Ginsenoside Rk1 exerts protective effects of LPS-induced podocyte apoptosis and inflammation by inactivating JAK2/STAT3 and NF-κB pathwaysXiaohong Ma, Linrong Pang, Feizhuang Shi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 13, 2025
Retraction Note: Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1Jinger Lu, Linrong Pang, Bo Zhang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 12, 2021
Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1Jinger Lu, Linrong Pang, Bo Zhang, et al.
Oncology Research and Treatment|September 26, 2015
Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell CarcinomaJia Huang, Wenhao Hu, Linrong Pang, et al.
Medicine|January 12, 2024
Whether specific genetic feature predicted immunotherapy efficacy: A case reportJun Chen, Linrong Pang, Lianxiang He, et al.
British Journal of Cancer|January 13, 2026
ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184Ze Rong, Jing Xing, Liangpei Wu, et al.
Oncotargets and Therapy|August 11, 2021
Acquired <i>ALK</i> Resistance Mutations Identified from Liquid Biopsy in an <i>ALK</i>-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case ReportBin Yao, Xue Han, Linrong Pang, et al.
Oncology Letters|January 19, 2018
Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2Linrong Pang, Jinger Lu, Jia Huang, et al.
Frontiers in Medicine|August 28, 2020
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the LiteratureHui Li, Xin Zhou, Ding Zhang, et al.
Pageof 2